Page last updated: 2024-09-05

repinotan hydrochloride and Parkinsonian Disorders

repinotan hydrochloride has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bezard, E; Gerlach, I; Gross, CE; Jork, R; Moratalla, R	1

Other Studies

1 other study(ies) available for repinotan hydrochloride and Parkinsonian Disorders

Article	Year
5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Neurobiology of disease, 2006, Volume: 23, Issue:1 Topics: Animals; Benzopyrans; Brain; In Situ Hybridization; Macaca; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Thiazoles; Tyrosine 3-Monooxygenase	2006

Article

Year

5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease.

Neurobiology of disease, 2006, Volume: 23, Issue:1

Topics: Animals; Benzopyrans; Brain; In Situ Hybridization; Macaca; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists; Thiazoles; Tyrosine 3-Monooxygenase

2006